1.66
-0.04 (-2.35%)
| Previous Close | 1.70 |
| Open | 1.69 |
| Volume | 464,000 |
| Avg. Volume (3M) | 1,733,370 |
| Market Cap | 3,295,000,320 |
| Price / Earnings (TTM) | 83.00 |
| Price / Sales | 1.72 |
| Price / Book | 1.29 |
| 52 Weeks Range | |
| Earnings Date | 26 Mar 2025 - 31 Mar 2025 |
| Profit Margin | 2.35% |
| Operating Margin (TTM) | 2.09% |
| Diluted EPS (TTM) | 0.020 |
| Quarterly Revenue Growth (YOY) | 0.10% |
| Quarterly Earnings Growth (YOY) | -51.40% |
| Total Debt/Equity (MRQ) | 45.27% |
| Current Ratio (MRQ) | 1.28 |
| Operating Cash Flow (TTM) | 32.99 M |
| Levered Free Cash Flow (TTM) | 7.26 M |
| Return on Assets (TTM) | 1.63% |
| Return on Equity (TTM) | 1.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | FRONTAGE | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| FRONTAGE | 3 B | - | 83.00 | 1.29 |
| LEPU BIO-B | 5 B | - | - | 4.75 |
| ALPHAMAB-B | 3 B | - | - | 1.88 |
| ABBISKO-B | 3 B | - | - | 1.21 |
| CSTONE PHARMA-B | 3 B | - | - | 5.94 |
| GENOR-B | 930 M | - | - | 0.800 |
|
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 73.33% |
| % Held by Institutions | 1.91% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |